WK Cancer Treatement Center

Clinical Trials

Relapsed Follicular Non-Hodgkin’s Lymphoma


To compare progression-free survival, overall response between two single-agents in patients with relapsed follicular lymphoma


  • Male and Female patients at least 18 years of age
  • Diagnosed and pathologically confirmed, Follicular Lymphoma Grade 1, 2, and 3A
  • Relapse or disease progression at least 6 months after completing their last prior treatment for Follicular Lymphoma
  • Radiographically measureable disease


  • Screening: 14 days
  • Treatment Period: 8 doses over 9 months
  • Follow-Up Period: every 26 weeks

Interested in Volunteering for the Study?

If you would like more information about this study, please call us at (318) 212-8671.